ReviewCancer drug resistance (Alhambra, Calif.)2019

Drug-adapted cancer cell lines as preclinical models of acquired resistance.

Martin Michaelis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.